India  

Pfizer's COVID Vaccine for Kids Under 5 Moves Closer to FDA Approval

Video Credit: Wibbitz Top Stories - Duration: 01:31s - Published
Pfizer's COVID Vaccine for Kids Under 5 Moves Closer to FDA Approval

Pfizer's COVID Vaccine for Kids Under 5 Moves Closer to FDA Approval

Pfizer's COVID Vaccine for Kids Under 5 , Moves Closer to FDA Approval .

Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete.

Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete.

The three-dose vaccine is for children between the ages of six months and five years.

Pfizer released a statement detailing the application.

Pfizer and BioNTech completed a rolling application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA)... , Pfizer Statement, via ABC News.

... of the 3-µg [microgram] dose of the Pfizer-BioNTech COVID-19 Vaccine.., Pfizer Statement, via ABC News.

... for children 6 months through 4 years of age (also referred to as 6 months to under 5 years of age) on June 1, 2022, Pfizer Statement, via ABC News.

Pfizer reported an 80 percent effectiveness rate in children in May.

The FDA also released a statement on June 1, confirming that the agency had accepted the Pfizer application.

We recognize parents are anxious to have their young children vaccinated against COVID-19... , FDA Statement, via ABC News.

... and while the FDA cannot predict how long its evaluation of the data and information will take, , FDA Statement, via ABC News.

... we will review any EUA request we receive as quickly as possible using a science-based approach, FDA Statement, via ABC News.

According to a poll conducted by the Kaiser Family Foundation in April of this year.

... just 18 percent of parents intend to have their children vaccinated once the vaccine is approved.

27 percent of parents stated that they will "definitely not" vaccinate their children against COVID


You Might Like


💡 newsR Knowledge: Other News Mentions

Food and Drug Administration Food and Drug Administration Agency of the US Department of Health and Human Services

U.K. Approves Vaccine Booster That Targets Omicron [Video]

U.K. Approves Vaccine Booster That Targets Omicron

U.K. Approves , Vaccine Booster , That Targets Omicron. The United Kingdom has become the first country to approve vaccine boosters specifically designed to counter the omicron variant of COVID-19. The United Kingdom has become the first country to approve vaccine boosters specifically designed to counter the omicron variant of COVID-19. NPR reports that the decision paves the way for people in the U.K. to receive their shots early in the fall season. The Moderna vaccine booster is "bivalent," meaning that it combines two different versions of the vaccine. Half of the mix is aimed at the original strain of COVID, while the other half is formulated to fight the original omicron variant. What this bivalent vaccine gives us is a sharpened tool in our armory to help protect us against this disease as the virus continues to evolve, Dr. June Raine, Head of the U.K.'s Medicines and Healthcare Products Regulatory Agency, via NPR. What this bivalent vaccine gives us is a sharpened tool in our armory to help protect us against this disease as the virus continues to evolve, Dr. June Raine, Head of the U.K.'s Medicines and Healthcare Products Regulatory Agency, via NPR. According to researchers in the U.K., the omicron booster "triggers a strong immune response" that defends against both the 2020 strain of COVID and omicron. According to researchers in the U.K., the omicron booster "triggers a strong immune response" that defends against both the 2020 strain of COVID and omicron. NPR points out that the combo booster differs from the omicron-specific booster which officials in the United States hope to roll out this fall. The U.S. FDA has requested vaccine developers to target later omicron variants BA.4 and BA.5. Those two strains currently make up a majority of cases in the U.S. According to NPR, officials hope to authorize omicron-specific boosters by mid-September

Credit: Wibbitz Top Stories    Duration: 01:31Published
Monkeypox Vaccine Maker Expresses Concern Over Dose-Splitting Plan [Video]

Monkeypox Vaccine Maker Expresses Concern Over Dose-Splitting Plan

Monkeypox Vaccine Maker , Expresses Concern , Over Dose-Splitting Plan. Bavarian Nordic makes the only monkeypox vaccine currently authorized by the Food and Drug Administration (FDA). The CEO of the company recently expressed concern about the Biden administration's plans to mitigate a vaccine shortage by splitting doses. CEO Paul Chaplin expressed his concerns in a letter recently sent to Health and Human Services Secretary (HHS) Xavier Becerra. We do have some reservations … due to the very limited safety data available, Paul Chaplin, Bavarian Nordic CEO, via 'The Washington Post'. According to Chaplin's letter, more studies to determine the efficacy of a split vaccine "would have been prudent.". His letter also states that the company has received numerous "calls from U.S. state government officials with questions and concerns.”. Responding to news of the vaccine maker's concerns, HHS Secretary Xavier Becerra expressed confidence with the Biden administration's plan. We’ve had conversations with them about this, and so has FDA, Xavier Becerra, HHS Secretary, via 'The Washington Post'. We wouldn’t have moved forward unless we thought it was safe and effective, and if FDA hadn’t dotted its I’s and crossed its T’s, Xavier Becerra, HHS Secretary, via 'The Washington Post'. Biden administration officials have speculated that Bavarian Nordic could be primarily concerned with a loss of profit. ... though Bavarian Nordic officials are adamant that the concerns of the company are safety focused. Officials connected to the U.S. monkeypox vaccine plan call it a "game changer.". It’s safe, it’s effective, and it will significantly scale the volume of vaccine doses available, Robert J. Fenton Jr., U.S. Monkeypox Response Co-Ordinator, via 'The Washington Post'

Credit: Wibbitz Top Stories    Duration: 01:30Published
FDA Favors Updated COVID Boosters for Fall, Shelves Summer Boosters [Video]

FDA Favors Updated COVID Boosters for Fall, Shelves Summer Boosters

FDA Favors , Updated COVID Boosters for Fall, , Shelves Summer Boosters . The Food and Drug Administration announced that its focus is now on updated boosters for those under 50. The shots are scheduled to be available to the public in September. Many health professionals feel it is the right decision and could help to bolster trust in federal health institutions. We can't give a booster now and then again in 1.5 months or two months – that will decrease trust, Dr. Monica Gandhi, UC San Francisco, via NPR News. Health professionals explained why two boosters in a short period of time could be "counter-productive.". If you get a booster now with the original formulation of the vaccine, this may in fact be counter-productive. , Dr. Celine Gounder, Kaiser Family Foundation, via NPR News. It may prevent the second booster dose given this fall from taking and from you developing an immune response to that booster, Dr. Celine Gounder, Kaiser Family Foundation, via NPR News. Others expressed skepticism at the effectiveness of the planned updated booster. People should not regard them as some sort of magic bullet that gives them super-strong protection, Dr. John Moore, Weill Cornell Medicine, via NPR News. These are not going to be magic bullet game-changers because they're not that much better than the already available vaccine boosters, Dr. John Moore, Weill Cornell Medicine, via NPR News. Other professionals feel the plan to wait may put people at an unnecessary risk. You're talking about you know literally hundreds of millions of people who are at a higher risk than they need to be for months, Dr. Robert Wachter, UC San Francisco, via NPR News. And that will mean potentially millions of preventable infections, certainly thousands of preventable hospitalizations, and probably hundreds of preventable deaths, Dr. Robert Wachter, UC San Francisco, via NPR News

Credit: Wibbitz Top Stories    Duration: 01:30Published
Drugmaker Asks FDA to Approve Over-the-Counter Birth Control Pill [Video]

Drugmaker Asks FDA to Approve Over-the-Counter Birth Control Pill

Drugmaker Asks FDA , to Approve Over-The-Counter , Birth Control Pill. On July 11, a French pharmaceutical company sought regulatory approval to sell an over-the-counter birth control pill in the United States. NBC reports that HRA Pharma's application comes amid legal and political battles regarding women's reproductive health. However, the company said the timing for its application was unrelated to the Supreme Court's recent decision to overturn Roe v. Wade. According to NBC, hormone based birth control has long been the most widely used form of birth control in the U.S. . Since the 1960s, birth control has required a prescription and a medical screening for conditions that raise the risk of blood clots. The French drugmaker argues that years of research suggest that women can safely screen themselves for those conditions and use the pill effectively. For a product that has been available for the last 50 years, that has been used safely by millions of women, we thought it was time to make it more available, Frederique Welgryn, HRA’s chief strategy officer, via 'The Guardian'. NBC reports that FDA approval could come as soon as next year. . Reproductive rights advocates have reportedly been pushing for the approval of more over-the-counter contraceptives following the Roe v. Wade decision . . Reproductive rights advocates have reportedly been pushing for the approval of more over-the-counter contraceptives following the Roe v. Wade decision . . Now, the FDA likely faces intense political scrutiny as it weighs a potentially precedent-setting decision

Credit: Wibbitz Top Stories    Duration: 01:31Published
FDA Calls for Fall COVID Boosters To Target Omicron Subvariants [Video]

FDA Calls for Fall COVID Boosters To Target Omicron Subvariants

FDA Calls for Fall COVID Boosters , To Target Omicron Subvariants. NBC News reports that on June 30, the Food and Drug Administration asked vaccine makers to modify upcoming booster shots to target subvariants of Omicron. The Omicron subvariants the agency wishes to target are BA.4 and BA.5. Officials have called on vaccine makers Pfizer-BioNTech and Moderna to produce bivalent vaccines, . which are intended to target the original strain of COVID-19 as well as its subvariants. As we move into the fall and winter, it is critical that we have safe and effective vaccine boosters that can provide protection... , Dr. Peter Marks, FDA, via NBC News. ... against circulating and emerging variants to prevent the most severe consequences of COVID-19. , Dr. Peter Marks, FDA, via NBC News. As of the week ending June 25, Omicron subvariants BA.4 and BA.5 were responsible for 52% of all new cases of COVID-19. Per the Centers for Disease Control and Prevention, BA.1, the first variant of Omicron, caused 0% of new cases. Pfizer and Moderna have thus far altered vaccines to target the original strain of COVID-19 and BA.1. which increased the immune response to earlier iterations, though both have waned in their efficacy against BA.4 and BA.5

Credit: Wibbitz Top Stories    Duration: 01:30Published

Pfizer Pfizer American multinational pharmaceutical and biotechnology corporation

Pfizer Announces $5.4 Billion Deal to Acquire Global Blood Therapeutics [Video]

Pfizer Announces $5.4 Billion Deal to Acquire Global Blood Therapeutics

Pfizer Announces , $5.4 Billion Deal , to Acquire Global Blood Therapeutics. Pfizer has announced a $5.4 billion deal for the blood disorder drugmaker. NBC reports that the news marks the latest attempt by Pfizer to combat declining demand for COVID-19 products as case numbers fall. The company has seen an unprecedented rise in sales since the global rollout of its COVID-19 vaccine. However, sales have begun to slow since the height of the pandemic. NBC reports that Pfizer is now seeking acquisitions that have the potential to boost sales by billions by the end of the decade. In May, Pfizer acquired migraine drugmaker Biohaven Pharmaceutical Holding for $11.6 billion. The company also recently completed a $6.7 billion deal to purchase Arena Pharmaceuticals. According to NBC, the acquisition of Global Blood Therapeutics would allow Pfizer to boost sales of Oxybryta. In 2019, Oxybryta was first approved as a treatment for Sickle Cell Disease. . An estimated 70,000 to 100,000 people in the United States are affected by Sickle Cell Disease, which is an inherited blood disorder. Following the announcement of the deal, shares of Global Blood rose 4.5%.

Credit: Wibbitz Top Stories    Duration: 01:31Published
Biden’s COVID-19 Symptoms Are Almost Gone, White House Doctor Says [Video]

Biden’s COVID-19 Symptoms Are Almost Gone, White House Doctor Says

Biden’s COVID-19 Symptoms Are Almost Gone, , White House Doctor Says. Last week, President Biden revealed he'd been diagnosed with COVID and was taking Paxlovid to treat his mild symptoms. . Last week, President Biden revealed he'd been diagnosed with COVID and was taking Paxlovid to treat his mild symptoms. . NPR reports that according to his physician, Dr. Kevin O'Connor, the president's symptoms "have now almost completely resolved.". NPR reports that according to his physician, Dr. Kevin O'Connor, the president's symptoms "have now almost completely resolved.". Dr. O'Connor says Biden currently has "residual nasal congestion and minimal hoarseness" following four days of taking Pfizer's antiviral pills. . Dr. O'Connor says Biden currently has "residual nasal congestion and minimal hoarseness" following four days of taking Pfizer's antiviral pills. . The president's pulse, blood pressure, temperature and oxygen levels are all normal. . NPR reports Biden is scheduled to remain in isolation through July 26. After that, if he receives a negative COVID test and feels well following his Paxlovid treatment. he could resume normal activities by July 27. The White House remains adamant that Biden's symptoms have been mild due to the fact that he is vaccinated and double boosted... ... in addition to starting Paxlovid as soon as he tested positive

Credit: Wibbitz Top Stories    Duration: 01:31Published
Elmo Gets Vaccinated Against COVID [Video]

Elmo Gets Vaccinated Against COVID

Elmo Gets Vaccinated , Against COVID. Earlier this month, Moderna and Pfizer/BioNTech vaccines were given emergency use authorization for children as young as six months old. The CDC also signed off on the shots for kids under 5. On June 28, 'Sesame Street' issued a public service announcement to spread the word. Elmo's dad, Louie, addressed getting his son vaccinated. Elmo's dad, Louie, addressed getting his son vaccinated. Was it safe? Was it the right decision?’ I talked to our pediatrician so I could make the right choice. I learned that Elmo getting vaccinated is the best way to keep himself, our friends, neighbors and everyone else healthy and enjoying the things they love, Louie, Elmo's dad, via 'Sesame Street'. According to a Kaiser Family Foundation Vaccine Monitor survey conducted in April, 38% of parents wanted to "wait and see" before vaccinating their young kids. According to a Kaiser Family Foundation Vaccine Monitor survey conducted in April, 38% of parents wanted to "wait and see" before vaccinating their young kids. Jeanette Betancourt, senior vice president of U.S. social impact at Sesame Workshop, issued a statement about the PSA. We hope that Louie and Elmo will inspire parents and caregivers across the country to speak with their healthcare providers and seek out information to learn about how the COVID-19 vaccines can keep young children and their families healthy, Jeanette Betancourt, senior vice president of U.S. social impact at Sesame Workshop, via CNN. The CDC reports that as of June 22, 30% of kids between the ages of 5 and 11 and 60% between the ages of 12 and 17 were fully vaccinated. The CDC reports that as of June 22, 30% of kids between the ages of 5 and 11 and 60% between the ages of 12 and 17 were fully vaccinated

Credit: Wibbitz Top Stories    Duration: 01:31Published
Pfizer Says Updated COVID-19 Shot Effective Against Omicron [Video]

Pfizer Says Updated COVID-19 Shot Effective Against Omicron

Pfizer Says Updated COVID-19 Shot , Effective Against Omicron. NBC News reports Pfizer announced on June 25 that its updated coronavirus vaccine better targets the omicron variant. Experts say while current vaccines offer ample protection against new variants, . their effectiveness has waned in the age of omicron. The Food and Drug Administration has considered ordering altered vaccines, . hoping a modified recipe could offer more protection when coronavirus surges again this fall and winter. Pfizer says after studying over 1,200 adults who had received three vaccine doses. officials say each of their vaccines showed a substantial increase in omicron-resistant antibodies. Based on these data, we believe we have two very strong omicron- adapted candidates. , statement from Pfizer CEO Albert Bourla, via NBC News. Pfizer's tweaked shot shows a 9 to 11-fold increase in omicron-fighting antibodies. almost 1.5 times higher than the company's initial dose

Credit: Wibbitz Top Stories    Duration: 01:30Published

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Nobody should be misled against allopathy: HC

Justice Anup Jairam Bhambhani, who was on Wednesday hearing a lawsuit against Ramdev by several doctors’ associations for allegedly spreading misinformation..
IndiaTimes

British travellers struggling to board flights after NHS COVID pass goes down

British travellers have been left struggling to board flights after the NHS COVID pass became unavailable.
Sky News

Delhi-NCR suffers from double whammy of COVID and flu, 80 per cent households hit by viral fever

On Thursday, the national capital recorded 1,964 fresh COVID-19 cases with a test positivity rate of 9.42 per cent, while eight more people died.
DNA
Japan Launches Campaign to Encourage Young People to Consume More Alcohol [Video]

Japan Launches Campaign to Encourage Young People to Consume More Alcohol

Japan Launches Campaign , to Encourage Young People , to Consume More Alcohol. CNN reports that the Japanese government has launched a contest to find new ways to encourage young people to drink more. CNN reports that the Japanese government has launched a contest to find new ways to encourage young people to drink more. Bars and other locations that sell alcohol have been hit hard by COVID restrictions, causing sales and liquor tax revenues to plunge in the world's third-largest economy. Bars and other locations that sell alcohol have been hit hard by COVID restrictions, causing sales and liquor tax revenues to plunge in the world's third-largest economy. The Japanese government's proposed solution, the "Sake Viva!" campaign, will be overseen by the National Tax Agency. The campaign invites participants to submit ideas for how to "stimulate demand among young people" for alcohol. . The proposed ideas can include new services, promotional methods, products, designs and even sales techniques utilizing the metaverse or artificial intelligence. According to the tax office, applications will be accepted until September 9. The winner of the contest will receive support for their concept to be commercialized. While the closure of bars throughout the pandemic drove "household consumption" up, the figures were unevenly distributed among different age groups. According to the Ministry of Economy, Trade and Industry, approximately 30% of people between the ages of 40 and 60 drink at least three days a week. However, just 7.8% of people in their 20s drank regularly. In this way, the decline in drinking habits year by year is thought to be having an effect on the shrinking of the domestic market, Japanese Ministry of Economy, Trade and Industry, via CNN

Credit: Wibbitz Top Stories    Duration: 01:31Published

COVID jab targeting both original strain and Omicron to be rolled out from 5 September

A COVID jab which targets both the original strain and Omicron will be rolled out across England from 5 September as part of the autumn booster programme.
Sky News

ABC News ABC News News division of Walt Disney Television

Alec Baldwin Must Have Pulled Trigger in 'Rust' Shooting, FBI Concludes

The FBI has concluded that Alec Baldwin must have fired the gun normally on the set of "Rust" -- which took Halyna Hutchins' life ... this according to a new..
TMZ.com
US Economy Added 528,000 Jobs in July [Video]

US Economy Added 528,000 Jobs in July

US Economy Added , 528,000 Jobs in July. According to data released by the Bureau of Labor Statistics on Aug. 5, . America added 528,000 nonfarm payrolls for July. The unemployment rate fell to 3.5%. The report exceeded Dow Jones estimates of 258,000 new jobs and an unemployment rate of 3.6% for the month. . July's 528,000 added jobs marks a significant increase from the 372,000 jobs added the month prior. . CNBC reports that average hourly earnings also increased 0.5% for July and 5.2% compared to a year ago. Daniel Zhao, a senior economist at the career site Glassdoor, says the increase in hiring contradicts typical recession conditions. It would be very unusual to have a recession when we’re still adding several hundred thousand jobs a month, Daniel Zhao, a senior economist at the career site Glassdoor, via ABC News. But as inflation remains at its highest level in over 40 years, the Federal Reserve continues to aggressively hike interest rates, which could slow job creation. But as inflation remains at its highest level in over 40 years, the Federal Reserve continues to aggressively hike interest rates, which could slow job creation. Recently, major companies such as Walmart and Robinhood have announced layoffs and hiring slowdowns. Recently, major companies such as Walmart and Robinhood have announced layoffs and hiring slowdowns

Credit: Wibbitz Top Stories    Duration: 01:30Published
Alyssa Farah Griffin Officially Joins 'The View' As New Conservative Host and Ana Navarro Inks New Multi-Year Deal | THR News [Video]

Alyssa Farah Griffin Officially Joins 'The View' As New Conservative Host and Ana Navarro Inks New Multi-Year Deal | THR News

ABC is making it official: Alyssa Farah Griffin is the new conservative co-host on The View.

Credit: The Hollywood Reporter    Duration: 01:26Published
Uncontained McKinney Fire Explodes Across Over 55,000 Acres of California [Video]

Uncontained McKinney Fire Explodes Across Over 55,000 Acres of California

Uncontained McKinney Fire , Explodes Across Over , 55,000 Acres of California. ABC reports that an out-of-control wildfire in Northern California has become the state's largest wildfire this year and now threatens a nearby town. The McKinney Fire has burned 55,493 acres in the Klamath National Forest in Siskiyou County near the Oregon border. As of August 1, the fire was 0% contained. According to Cal Fire, strong winds drove the blaze across almost 3,000 acres of the drought-dry area overnight. In the town of Klamath River, two people were found dead in a car parked in their driveway. Siskiyou County Sheriff Jeremiah LaRue told ABC News that firefighters believe the couple was caught by the fast-moving fire as they attempted to flee. Officials say the fire started around 2:15 P.M. on July 29. The fire soon forced officials to close Highway 96 and order the evacuation of several communities, including a partial evacuation of Yreka, California. According to the Siskiyou County Sheriff's Office, over 100 structures have been destroyed, mostly along the Klamath River which runs parallel to Highway 96. According to Cal Fire, at least 849 firefighters are combating the fire on the ground and from the air.

Credit: Wibbitz Top Stories    Duration: 01:31Published
H.E.R. To Star As Belle in Upcoming ‘Beauty and the Beast’ Animated, Live-Action Special [Video]

H.E.R. To Star As Belle in Upcoming ‘Beauty and the Beast’ Animated, Live-Action Special

H.E.R. To Star As Belle in Upcoming , ‘Beauty and the Beast’ Animated, Live-Action Special. On July 20, ABC announced that H.E.R. has been cast as Belle for 'Beauty and the Beast: A 30th Celebration.'. H.E.R. is the perfect embodiment of our Belle and we are thrilled for our audiences to see her in this celebration of creativity. , Jon M. Chu, executive producer, via ABC News. We were both influenced as storytellers by the original animated movie, so it's very exciting to collaborate together to honor the artistry of that timeless classic while also inspiring a whole new generation of creators, Jon M. Chu, executive producer, via ABC News. The role will make H.E.R. the first Black and Filipina woman to play Belle on screen. The world will see a Black and Filipino Belle! I can't believe I get to be a part of the 'Beauty and the Beast' legacy, H.E.R., via ABC News. I have always wanted to be a Disney princess, and I get to work with two wonderful directors, Hamish Hamilton and my favorite, Jon M. Chu. It is very surreal and I couldn’t be more grateful, H.E.R., via ABC News. The two-hour special will be taped in front of a live audience. It will air on ABC on Dec. 15. Disney+ subscribers will be able to watch it the following day

Credit: Wibbitz Top Stories    Duration: 01:30Published

BioNTech BioNTech German biotechnology company


Kaiser Family Foundation Kaiser Family Foundation American non-profit organization


Related videos from verified sources

FDA Panel Endorses COVID Vaccines for Children Under 5 [Video]

FDA Panel Endorses COVID Vaccines for Children Under 5

FDA Panel , Endorses COVID Vaccines, for Children Under 5. On June 15, an advisory panel to the United States Food and Drug Administration voted to recommend two COVID-19 vaccines for kids ages 5..

Credit: Wibbitz Top Stories     Duration: 01:30Published